Cargando…
TPX2 silencing exerts anti-tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway
Hepatocellular carcinoma (HCC) is one of the primary causes of cancer-associated deaths worldwide. Current treatment methods include surgical resection, chemotherapy and radiotherapy; however the curative rate remains low, thus novel treatments are required. The aim of the present study was to inves...
Autores principales: | Huang, Dan-Hong, Jian, Jie, Li, Shuang, Zhang, Yan, Liu, Li-Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844623/ https://www.ncbi.nlm.nih.gov/pubmed/31638175 http://dx.doi.org/10.3892/ijmm.2019.4371 |
Ejemplares similares
-
TPX2 promotes glioma cell proliferation and invasion via activation of the AKT signaling pathway
por: Gu, Jian-Jun, et al.
Publicado: (2016) -
Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways
por: Wang, Fei, et al.
Publicado: (2022) -
The Silencing of Pokemon Attenuates the Proliferation of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Inhibiting the PI3K/Akt Pathway
por: Lin, Chan-Chan, et al.
Publicado: (2012) -
TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway
por: Yu, Xi, et al.
Publicado: (2021) -
Terpenoid natural products exert neuroprotection via the PI3K/Akt pathway
por: Xu, Bingyao, et al.
Publicado: (2022)